Asthma COPD Overlap (ACO)
Asthma and chronic obstructive pulmonary disease (COPD) are the most common chronic airway disorders worldwide. The overlap of asthma and COPD is a problem that has been discussed for a long time, and there was previously no unified name or definition of this condition. The Global Initiative for Asthma (GINA), an international committee examining asthma, and the Global Initiative for Chronic Obstructive Lung Disease (GOLD), an international committee examining COPD, jointly proposed the concept of “Asthma/COPD Overlap Syndrome (ACOS)” (currently named “asthma/COPD overlap (ACO).” However, it is unclear how to identify ACO as a clinically useful disease entity. In this chapter, we discussed clinical features and biomarkers to differentiate asthma, COPD, and ACO in elderly patients on the basis of the definition of GINA guideline and described historical background and prevalence and treatment of ACO.
KeywordsAsthma Global Initiative for Chronic Obstructive Lung Disease (GOLD) Asthma/COPD overlap (ACO) Dutch hypothesis British hypothesis
- 4.Orie NGM, Sluiter HJ, de Vries K, Tammeling GJ, Witkop J. The host factor in bronchitis. In: Orie NGM, Sluiter HJ, editors. Bronchitis. Assen: Royal van. Gorcum; 1961. p. 43–59.Google Scholar
- 7.Global initiative for asthma. Global strategy for asthma management and prevention. 2017. http://ginasthma.org/2017-gina-report-global-strategy-for-asthma-management-and-prevention/.
- 8.Global strategy for the diagnosis, Management and prevention of chronic obstructive pulmonary disease (GOLD). 2017.Google Scholar
- 22.Pascoe S, Locantore N, Dransfield MT, et al. Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials. Lancet Respir Med. 2015;3:435–42.CrossRefGoogle Scholar
- 40.James AJ, Reinius LE, Verhoek M, Gomes A, Kupczyk M, Hammar U, Ono J, Ohta S, Izuhara K, Bel E, Kere J, Söderhäll C, Dahlén B, Boot RG, Dahlén SE, BIOAIR (Longitudinal Assessment of Clinical Course and Biomarkers in Severe Chronic Airway Disease) Consortium. Increased YKL-40 and Chitotriosidase in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2016;193(2):131–42.CrossRefGoogle Scholar